This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy

Professionals 236 Users Online

Enthesopathy Treatment Market

Enthesopathy Treatment Market: Global Industry Analysis and Forecast 2017 - 2025

Enthesopathy Treatment Market Segmented By medical conditions such as Plantar Fasciitis, Ankylosing Spondylitis, Spondyloarthropathy, Rotator-Cuff Syndrome and Achilles Tendonitis with treatment such as Corticosteroids, NSAIDs, Autologous Blood Patch, Extra corporeal Shockwave Lithotripsy (ESWT) and Radiotherapy


Enthesopathy is derived from a combination of entheso means a specific structure within the musculoskeletal system and pathy means presence of pathology. Enthesis was previously considered as the area where tendons in the body join the bone. But with the increasing research and pathological exploration, the term enthesis is now referred to as a disorder where ligaments, joint capsule and muscles join into the bone.

The treatment of enthesis is complex as there are number of structures that are in close proximity to the enthesis. The enthesis organ is the most common target for attack in a number of systemic rheumatoid arthritis, more specifically the sero-negative spondyloarthropathies.

Enthesopathy is encountered more in the sporting, fitness population or those who perform a repetitive task under load. While delivering an enthesopathy treatment it’s important to consider the presence of rheumatic diseases and other metabolic illnesses such as high cholesterol, diabetes and endocrine disorders.

Sample Report

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

Enthesopathy Treatment Market: Dynamics

The demand for enthesopathy treatment is expected to upsurge owing to the increasing number of sports injury, rising number of population going for workouts for good fitness score and the growing number of pathological research and increasing number of product pipeline by industry players. In around 4% of the population enthesopathy precede arthritis and is accompanied with morning heel pain and foot stiffness.

Moreover, industry players are involved in expanding the product portfolio related to rheumatology. Janssen Biotech, Inc. presented more than 35 articles related to rheumatology portfolio at the American College of Rheumatology. The data included efficacy and safety data from Phase 3 studies of Stelara, Simponi Aria and Simponi.

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

Enthesopathy Treatment Market: Segmentation

Attribute Details
On the basis of medical conditions
  • Plantar Fasciitis
  • Ankylosing Spondylitis
  • Spondyloarthropathy
  • Rotator-Cuff Syndrome
  • Achilles Tendonitis
  • Others
On the basis of treatment
  • Corticosteroids
  • NSAIDs
  • Autologous Blood Patch
  • Extra corporeal Shockwave Lithotripsy (ESWT)
  • Radiotherapy
  • Others
Market Research Methodology

Market Research Methodology

-Perfect through Years of Diligence

Check Research Methodology

Enthesopathy Treatment Market: Region-wise Outlook

North America dominated the enthesopathy market owing to the industry participant research undertakings and government efforts towards arthritis treatment awareness. Ultragenyx Pharmaceutical, Inc. initiated a Phase 3 study for the treatment of pediatric patients with X-linked hypophosphatemia (XLH). XLH is a condition wherein there is inadequate mineralization of bones which leads to abnormalities such as enthesopathy, osteoarthritis and many more.

Moreover, in the U.S. arthritis is not limited to older person but also prevalent in children. On the Juvenile Arthritis Awareness month there were 250 children diagnosed with juvenile arthritis.

Asia Pacific is expected to be fastest growing region owing to the high incidence rate of arthritis thus posing a high enthesopathy treatment opportunity for international as well as domestic players. In India, obesity precede arthritis and hence the incidence rate of arthritis is high.

Sales Team

Sales Team
Client Partner

Let's Connect

Connect me to identify winning opportunities

Ask An Expert
I'm Available

Enthesopathy Treatment Market: Market Players

Some of the enthesopathy treatment market contributors include Abbott Laboratories, Accuray Incorporated, Boston Scientific Corporation, C.R. Bard, Inc., Eli Lilly and Company, Janssen Biotech, Inc., Pfizer, Inc., Siemens AG, Varian Medical Systems, Inc., and Ultragenyx Pharmaceutical, Inc.

- Companies Covered in This Report -

Google translate